Celladon says heart treatment fails in trial
April 26, 2015 at 17:44 PM EDT
NEW YORK, April 26 (Reuters) - Celladon Corp said its heart failure gene therapy Mydicar failed to meet its primary and secondary endpoints in an important trial.